Topic: Central Europe

Valeant Pharmaceuticals and Kadmon Announce Strategic Agreement for Antiviral Therapeutics

Drugs.com - 461 days ago
VRX) and Kadmon Pharmaceuticals LLC have concluded two strategic agreements for the development and commercialization of taribavirin and the commercial marketing of ribavirin in the treatment of viral diseases, including hepatitis C virus (HCV). Under a separate agreement, Valeant has paid Kadmon ...

ADDRESSING HCV INFECTION IN EUROPE REPORTED ESTIMATED AND UNDIAGNOSED CASES

The Encyclopedia Britannica - 583 days ago
The hepatitis C virus (HCV) is a major public health problem due to its high prevalence, high rate of onward transmission and health complications. Secondary sources were assessed and experts in 17 European countries were interviewed about HCV prevalence, reporting strategies and ...